Alaaeldin Ahmed Hamza
Biology , Department of Hormones · National Organization for Drug control and Researc
Research Interests
My experience has involved drug discovery, mechanism-of-action studies, biomarker development, cancer pharmacology in xenograft and chemical tumor models, pharmacology of stress response signaling .This has required a broad understanding of cancer biology and...
Biography
Dr. Alaaeldin Ahmed Hamza, who earned his PhD from Cairo University in Animal Physiology, is currently working as an Emeritus professor of physiology at the National Organization for Drug Control and Research (NODCAR) in Egypt. He is an established scientist in the fields of liver toxicity, reproductive toxicity, and liver cancer. He was awarded the best individual non-funded research project award at the 9th Annual Research Conference, U.A.E. University, Al-Ain April 21–23, 2008. Based on his highly cited publications, he has been ranked among the top scientists in United Arab Emirates institutions according to GSC public profiles from 2017 to 2024 and among the top 2% of the world's scientists by Stanford University from 2020 to 2023.
Education
Cairo University, Cairo, Egypt 2004 Ph.D., Animal Physiology, Zoology Department, Faculty of Science Cairo University,Cairo, Egypt 1995 M.Sc., Animal Physiology, Zoology Department, Faculty of Science Ain –Shams University, Cairo, Egypt 1987 Institut of Environmental Studies and Research Diploma, In Enviromental Biological Sciences Cairo University, Cairo, Egypt 1983 B.Sc., Zoology Department, Faculty of Science
Recent Scopus Publications
- Gallic and glycyrrhetinic acids prevent azithromycin-induced liver damage in rats by mitigating oxidative stress and inflammation
- Withania somnifera Ameliorates Doxorubicin-Induced Nephrotoxicity and Potentiates Its Therapeutic Efficacy Targeting SIRT1/Nrf2, Oxidative Stress, Inflammation, and Apoptosis
- Combining In Vitro, In Vivo, and Network Pharmacology Assays to Identify Targets and Molecular Mechanisms of Spirulina-Derived Biomolecules against Breast Cancer
- Hibiscus-cisplatin combination treatment decreases liver toxicity in rats while increasing toxicity in lung cancer cells via oxidative stress- apoptosis pathway
- Combining Crocin and Sorafenib Improves Their Tumor-Inhibiting Effects in a Rat Model of Diethylnitrosamine-Induced Cirrhotic-Hepatocellular Carcinoma
Grants / Consultancy
• Bioavailability of Itraconazole-β-cyclodextrin Complex. (2003). • Establish post natal mammalian neuronal system from different regions of the brain for isolation and...
Links
- ORCID https://orcid.org/0000-0001-5450-1116
- Google Scholar https://scholar.google.com/citations?user=Alaaeldin A. Hamza
- Scopus https://www.scopus.com/authid/detail.uri?authorId=16175187900
- Personal Weblink https://www.researchgate.net/profile/Alaaeldin-Hamza